During the past decade, Robarts Research Institute conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Robarts Research Institute" #1 sponsor was "Western University, Canada" with 9 trials, followed by "Dr. Grace Parraga" with 5 trials sponsored, "University of Western Ontario, Canada" with 3 trials sponsored, "Aegerion Pharmaceuticals, Inc." with 2 trials sponsored and "Arrowhead Pharmaceuticals" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Robarts Research Institute" #1 collaborator was "London Health Sciences Centre" with 5 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "University of Western Ontario, Canada" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Academy of Finland" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Robarts Research Institute" are "Asthma" (3 trials), "Hypertriglyceridemia" (3 trials), "Bronchiectasis" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Robarts Research Institute" in a lesser frequency.

Most popular intervention types in "Robarts Research Institute" are "Drug" (17 trials), "Other" (11 trials), "Device" (7 trials), "Diagnostic Test" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "MRI" (3 trials), "ARO-APOC3" (2 trials), "Hyperpolarized Xenon MRI" (2 trials) and "Oscillating Positive Expiratory Pressure (Aerobika ®)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Robarts Research Institute" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Robarts Research Institute". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Robarts Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Robarts Research Institute, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".